Scinovex
article Open AccessTop 1% cited

Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

JNCI Journal of the National Cancer Institute · 2011 · Vol. 103(19) · pp. 1452–1460
Walter J. CurranRebecca PaulusCorey J. LangerR. KomakiJong Seok LeeStephen L. HauserB. MovsasTodd H. WassermanSeth A. RosenthalElizabeth GoreMitchell MachtayWilliam T. SauseJames D. Cox

Abstract

Concurrent delivery of cisplatin-based chemotherapy with TRT confers a long-term survival benefit compared with the sequential delivery of these therapies.

Lung Cancer Diagnosis and TreatmentLung Cancer Treatments and MutationsHepatocellular Carcinoma Treatment and PrognosisMedicineRegimenEtoposideRadiation therapyChemotherapyLung cancerVinblastineClinical endpointChemotherapy regimenCisplatin

MeSH terms

AdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsCanadaCarcinoma, Non-Small-Cell LungCisplatinDrug Administration ScheduleEtoposideFollow-Up StudiesHumansLung NeoplasmsMaleMiddle AgedNeoplasm Staging
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410 · Scinovex